Shares of iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI – Get Free Report) traded up 0.9% on Wednesday . The company traded as high as $31.83 and last traded at $31.70. 3,305 shares were traded during mid-day trading, an increase of 70% from the average session volume of 1,940 shares. The stock had previously closed at $31.42.
iShares LifePath Target Date 2065 ETF Stock Performance
The stock has a market capitalization of $8.19 million, a P/E ratio of 20.90 and a beta of 0.96. The stock has a 50-day moving average price of $32.09 and a two-hundred day moving average price of $32.04.
Institutional Investors Weigh In On iShares LifePath Target Date 2065 ETF
An institutional investor recently bought a new position in iShares LifePath Target Date 2065 ETF stock. Heck Capital Advisors LLC acquired a new position in iShares LifePath Target Date 2065 ETF (NYSEARCA:ITDI – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 3,501 shares of the company’s stock, valued at approximately $110,000. Heck Capital Advisors LLC owned about 2.50% of iShares LifePath Target Date 2065 ETF as of its most recent filing with the SEC.
iShares LifePath Target Date 2065 ETF Company Profile
The iShares LifePath Target Date 2065 ETF (ITDI) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.
Recommended Stories
- Five stocks we like better than iShares LifePath Target Date 2065 ETF
- What is the Dow Jones Industrial Average (DJIA)?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- How to start investing in penny stocks
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- About the Markup Calculator
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for iShares LifePath Target Date 2065 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2065 ETF and related companies with MarketBeat.com's FREE daily email newsletter.